BlogLongevity Biomarkers

You've Tracked Your VO2 Max and HRV. Here's Why Muscle Health Is the Missing Variable in Your Longevity Stack.

3 min read

Smiling man with his arms crossed in front of a wall of kettlebells
Photo · Pexels

I know people who have spent thousands of dollars building out a meticulous longevity tracking stack. Continuous glucose monitors. Quarterly bloodwork panels including ApoB, Lp(a), CRP, homocysteine. Regular DEXA scans. VO2 max testing. HRV tracking. These are serious, evidence-based investments in understanding their physiology.

Most of them have never had a clinical assessment of their functional musculoskeletal health. When I ask about strength benchmarks relative to their age group, or power output trends over the past five years, or single-leg balance performance, the answer is almost always some version of "I train, so I assume I'm doing okay." That assumption, as the longevity research increasingly shows, is not safe to make.

Muscle strength predicts mortality independent of cardiorespiratory fitness

The study that makes this most clearly is the 2018 JAMA Network Open analysis of 122,007 adults who underwent both cardiopulmonary exercise testing and muscle strength assessment and were followed for a median of 8.4 years. The finding: low muscle strength was associated with significantly higher all-cause mortality independent of cardiorespiratory fitness. People with high VO2 max but low muscle strength still had meaningfully elevated mortality risk compared to people with high levels of both.

This is not a nuanced secondary finding. It means VO2 max and functional muscle strength are measuring different physiological systems with independent mortality associations. Optimizing one does not protect you against the outcomes associated with low levels of the other. A longevity stack without functional muscle health data is tracking half the picture.

A 2024 Mayo Clinic Proceedings study extended this specifically to muscle power — the rate of force production, which is distinct from maximum strength — finding it was independently associated with lower all-cause mortality after controlling for aerobic fitness, body composition, and total exercise volume.

Skeletal muscle is not just structural tissue — it's a longevity organ

The deeper case for muscle health as a longevity biomarker goes beyond the strength-mortality correlations. Skeletal muscle is the largest insulin-sensitive tissue in the body and the primary site of glucose disposal after meals. Muscle mass and quality directly determine insulin sensitivity — and as Peter Attia has articulated clearly in his metabolic disease prevention framework, insulin sensitivity erosion is the central upstream mechanism in type 2 diabetes, cardiovascular disease, and many neurodegenerative conditions.

Skeletal muscle also functions as an amino acid reservoir mobilized during physiological stress: illness, surgery, injury, recovery. A 2021 JAMA Surgery study found low skeletal muscle mass was an independent predictor of postoperative complications and hospital length of stay across multiple surgical procedures. The margin between people who recover quickly and people who do not is, in part, a muscle mass story.

Muscle also produces myokines during contraction — signaling molecules with systemic anti-inflammatory and neuroprotective effects. Regular mechanical stimulation of skeletal muscle is, by the available evidence, a pharmacological intervention against chronic inflammation and neurodegeneration.

Why DEXA lean mass doesn't tell you what you think it tells you

A DEXA scan showing stable lean mass is reassuring but incomplete as a longevity biomarker. Two people with identical DEXA lean mass scores can have dramatically different functional strength, power output, and movement quality — because mass does not capture muscle fiber type distribution, motor unit recruitment efficiency, or intramuscular fat infiltration.

A 2024 Journal of Gerontology study found that functional performance measures — grip strength, chair stand performance, gait speed — predicted 10-year mortality and functional disability more accurately than lean mass alone. What muscle can do matters more than how much of it there is. For a deeper look at exactly what DEXA misses, read What a DEXA Scan Actually Tells You About Muscle Health — And What It Misses.

The longevity biomarker layer missing from most tracking stacks

VO2 max, HRV, glucose regulation, inflammatory markers, sleep quality — these are all clinically meaningful longevity biomarkers worth tracking. Functional musculoskeletal health, assessed across strength, power, endurance, balance, and mobility and benchmarked against age-stratified norms, captures a dimension of physiological capacity none of those other metrics address: your actual ability to produce force, maintain stability, and sustain physical effort across the decades ahead.

The people I know with the most sophisticated health stacks have invested real money in partial pictures of their physiology. Adding the musculoskeletal layer does not replace what they have. It completes it.

More from the blog